Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine ...

BTIG analyst Mark Massaro reiterated a Buy rating on Zoetis (ZTS – Research Report) yesterday and set a price target of $200.00. The company’s shares closed yesterday at $165.17. Easily ...

Wetteny Joseph Says Agility, A Strong Category And The Embrace Of Technology Has Led The Company To Continued Growth And Likely Future Stability.

Click the Use this template button and clone it in IntelliJ IDEA. IntelliJ Platform Plugin Template is a repository that provides a pure template to make it easier to create a new plugin project ...